Medical Department MEA, NBG, Aarhus University Hospital
Aarhus C, Jylland, 8000, Denmark
NCT Number: NCT01705782
The purpose of the study is to investigate the metabolic effects during acute inflammation with and without the nutritional supplement of amino acids.
E. Coli Endotoxin (LPS, lipopolysaccharide) is used to initiate an inflammatory response.
The study is an interventional randomized placebo study including 8 healthy male subjects. Each subject participates 3 times (different days) and are given one of following interventions:
* Placebo (NaCl) * Endotoxin, US standard reference E.Coli + Placebo (NaCl) * Endotoxin, US standard reference E.Coli + Amino acids (intravenously)
It is our hypothesis that the nutritional intervention during acute inflammation plays an important role in lipid and protein metabolism.
Looking for future studies?
Notify Me25 year and older
Male
Interventional
Not applicable
Aarhus C, Jylland, 8000, Denmark
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: After 6 hours intervention
Protein catabolism is measured with amino acid tracer techniques comparing radioactive marked amino acids from blood samples.
Time frame: At 2 hours and 4,5 hours
A muscle + fat biopsy are taken twice during the intervention to focus on the local effects in these tissues.
Time frame: 6 hours
Lipid and glucose metabolism are measured with tracer techniques with radioactive marked glucose + lipid.
University of Aarhus
Other
Metabolic Effects of Endotoxin Induced Acute Inflammation in Healthy Young Men With and Without Supplement of Amino Acids.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01906619
Acid-Base Imbalance, Alkalosis
Berlin, Germany
View Trial DetailsNCT07134751
Bacteremia, Bacterial Infections
Gothenburg, Sweden
View Trial DetailsNCT07345286
Biomarkers, Febrile Illness Acute
Kinshasa, Democratic Republic of the Congo
View Trial DetailsNCT05236374
Cardiovascular Diseases, Inflammation
Davis, California, United States
View Trial Details